Charles D Blanke Selected Research

Charles D Blanke Research Topics

Disease

54	Neoplasms (Cancer) 03/2024 - 03/2002
23	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 03/2002
21	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 04/2002
11	Adenocarcinoma 04/2017 - 09/2003
8	Leukemia 03/2024 - 11/2005
7	Disease Progression 02/2024 - 01/2006
6	Colonic Neoplasms (Colon Cancer) 12/2023 - 12/2005
5	Neutropenia 01/2021 - 04/2010
5	Diarrhea 01/2021 - 08/2002
5	Fatigue 01/2020 - 08/2002
5	Esophageal Neoplasms (Esophageal Cancer) 05/2012 - 04/2005
4	Cholangiocarcinoma 03/2023 - 12/2011
4	Nausea 01/2021 - 07/2011
4	Neoplasm Metastasis (Metastasis) 04/2017 - 04/2006
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2017 - 08/2010
3	Gallbladder Neoplasms (Gallbladder Cancer) 02/2024 - 12/2011
3	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2015
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 11/2014
3	Carcinoma (Carcinomatosis) 08/2015 - 04/2006
3	Stomach Neoplasms (Stomach Cancer) 07/2012 - 10/2006
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2005 - 03/2002
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
2	Thrombocytopenia (Thrombopenia) 01/2021 - 10/2014
2	Leukopenia 01/2021 - 03/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 04/2015
2	Hypertension (High Blood Pressure) 05/2017 - 03/2015
2	Hepatocellular Carcinoma (Hepatoma) 03/2015 - 05/2008
2	Pain (Aches) 08/2010 - 04/2002
2	Arthritis (Polyarthritis) 01/2005 - 04/2002
1	Anemia 01/2021
1	Stomatitis 01/2021
1	Vomiting 01/2021
1	Hypothyroidism 01/2020
1	Neuroendocrine Carcinoma 01/2020
1	Microsatellite Instability 10/2019
1	Exanthema (Rash) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Acne Vulgaris 01/2018

Drug/Important Bio-Agent (IBA)

23	Imatinib Mesylate (Gleevec)FDA Link 11/2023 - 03/2002
12	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 01/2005
11	Cetuximab (Erbitux)FDA Link 03/2024 - 08/2010
8	Phosphotransferases (Kinase)IBA 11/2023 - 03/2002
8	Gemcitabine FDA Link 04/2017 - 07/2002
7	Bevacizumab (Avastin)FDA Link 03/2024 - 06/2011
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2009
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 09/2003
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 12/2011
5	ErbB Receptors (EGF Receptor)IBA 10/2014 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 07/2007
4	IpilimumabIBA 02/2024 - 01/2020
4	NivolumabIBA 02/2024 - 01/2020
4	Sodium Glutamate (Accent)IBA 11/2021 - 01/2010
4	Capecitabine (Xeloda)FDA Link 01/2021 - 12/2011
4	Leucovorin (Folinic Acid)FDA Link 12/2018 - 01/2005
4	Celecoxib (Celebrex)FDA Link 12/2018 - 04/2002
4	Tyrosine Kinase InhibitorsIBA 01/2010 - 03/2002
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2018 - 01/2005
3	Tyrosine (L-Tyrosine)FDA Link 12/2015 - 04/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015 - 08/2012
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2009 - 03/2002
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2008 - 08/2002
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2023 - 12/2003
2	Protein Isoforms (Isoforms)IBA 11/2023 - 12/2003
2	AntibodiesIBA 01/2018 - 01/2011
2	MK 2206IBA 04/2017 - 07/2015
2	Monoclonal AntibodiesIBA 12/2015 - 08/2010
2	Sorafenib (BAY 43-9006)FDA Link 03/2015 - 08/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2014 - 10/2006
2	Cisplatin (Platino)FDA LinkGeneric 05/2012 - 04/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 09/2003
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2005 - 04/2002
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2005 - 04/2002
1	Dietary Fats (Dietary Fat)IBA 01/2023
1	LuciferasesIBA 01/2021
1	AdiponectinIBA 01/2021
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	PlatinumIBA 12/2020
1	Coffee FDA Link 11/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	hydroxide ionIBA 12/2019
1	Vitamin D FDA LinkGeneric 12/2019
1	25-hydroxyvitamin DIBA 12/2019
1	Genetic Markers (Genetic Marker)IBA 10/2019
1	Interferon alpha-2 (Roferon-A)FDA Link 05/2017

Therapy/Procedure

37	Therapeutics 03/2024 - 03/2002
28	Drug Therapy (Chemotherapy) 03/2024 - 04/2002
10	Radiotherapy 08/2015 - 04/2005
5	Neoadjuvant Therapy 01/2018 - 04/2005
2	Adjuvant Chemotherapy 03/2023 - 01/2021
2	Immunotherapy 01/2022 - 12/2020
2	Chemoprevention 01/2018 - 12/2011
2	Chemoradiotherapy 07/2012 - 02/2007
2	Combination Drug Therapy (Combination Chemotherapy) 07/2011 - 02/2005
2	Combined Modality Therapy 04/2005 - 02/2005
1	Biological Therapy 12/2019
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Induction Chemotherapy 01/2018
1	Palliative Care (Palliative Therapy) 10/2017